Seqens

As a global leader in pharmaceutical solutions, custom specialties and personal care, the Seqens Group relies on 300 scientists in 10 Research and Development centers and 3,200 employees. Seqens develops tailor-made specialty products and manufactures high-value-added specialty chemicals for small- and large-scale applications.